{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:05Z","timestamp":1791052085118,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540293828","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-36583-4_14","type":"book-chapter","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T18:34:18Z","timestamp":1158690858000},"page":"247-268","source":"Crossref","is-referenced-by-count":43,"title":["Mass Vaccination: Solutions in the Skin"],"prefix":"10.1007","author":[{"given":"G. M.","family":"Glenn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/S0264-410X(99)00379-5","volume":"18","author":"M.E. Baca-Estrada","year":"2000","unstructured":"Baca-Estrada ME, Foldvari M, Ewen C, Badea I, and Babiuk LA (2000) Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine 18:1847\u20131854","journal-title":"Vaccine"},{"key":"14_CR2","first-page":"693","volume":"78","author":"D.J. Briggs","year":"2000","unstructured":"Briggs DJ, Banzhoff A, Nicolay U, Sirikwin S, Dumavibhat B, Tongswas S, Wasi C (2000) Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Bull World Health Organ 78:693\u2013698","journal-title":"Bull World Health Organ"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinids\/14.3.697","volume":"14","author":"J.P. Bryan","year":"1992","unstructured":"Bryan JP, Sjogren MH, Perine PL, Legters LJ (1992) Low-dose intradermal and intramuscular vaccination against hepatitis B. Clin Infect Dis 14:697\u2013707","journal-title":"Clin Infect Dis"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1016\/S0264-410X(00)00544-2","volume":"19","author":"D. Chen","year":"2001","unstructured":"Chen D, Erickson CA, Endres RL, Periwal SB, Chu Q, Shu C, Maa YF, Payne LG (2001) Adjuvantation of epidermal powder immunization. Vaccine 19:2908\u20132917","journal-title":"Vaccine"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1046\/j.1365-2133.2000.03464.x","volume":"142","author":"T. Christoph","year":"2000","unstructured":"Christoph T, Muller-Rover S, Audring H, Tobin DJ, Hermes B, Cotsarelis G, Ruckert R, Paus R (2000) The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol 142:862\u2013873","journal-title":"Br J Dermatol"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/IAI.63.5.1617-1623.1995","volume":"63","author":"B.L. Dickinson","year":"1995","unstructured":"Dickinson BL, Clements JD (1995) Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect Immun 63:1617\u20131623","journal-title":"Infect Immun"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.vaccine.2004.06.036","volume":"23","author":"S.A. Frech","year":"2005","unstructured":"Frech SA, Kenney RT, Spyr CA, Lazar H, Viret JF, Herzog C, Gluck R, Glenn GM (2005) Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 23:946\u2013950","journal-title":"Vaccine"},{"key":"14_CR8","first-page":"215","volume":"236","author":"L.C. Freytag","year":"1999","unstructured":"Freytag LC, Clements JD (1999) Bacterial toxins as mucosal adjuvants. Curr Top Microbiol Immunol 236:215\u2013236","journal-title":"Curr Top Microbiol Immunol"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/36014","volume":"391","author":"G.M. Glenn","year":"1998","unstructured":"Glenn GM, Rao M, Matyas GR, Alving CR (1998) Skin immunization made possible by cholera toxin. Nature 391:851","journal-title":"Nature"},{"key":"14_CR10","unstructured":"Glenn GM, Alving CR (1999a) Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin. European Patent No. 1061951"},{"key":"14_CR11","volume-title":"Adjuvant for transcutaneous immunization","author":"G.M. Glenn","year":"1999","unstructured":"Glenn GM, Alving CR (1999b) Adjuvant for transcutaneous immunization. US Patent No. 5,980,898. The United States of America as represented by the U.S. Army Medical Research & Material Command (Washington, DC)"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/82225","volume":"6","author":"G.M. Glenn","year":"2000","unstructured":"Glenn GM, Taylor DN, Li X, Frankel S, Montemarano A, Alving CR (2000) Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 6:1403\u20131406","journal-title":"Nat Med"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1586\/14760584.2.2.253","volume":"2","author":"G.M. Glenn","year":"2003","unstructured":"Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP (2003) Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines 2:253\u2013267","journal-title":"Expert Rev Vaccines"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1086\/315337","volume":"181","author":"R. Gl\u00fcck","year":"2000","unstructured":"Gl\u00fcck R, Mischler R, Durrer P, Furer E, Lang AB, Herzog C, Cryz SJ, Jr. (2000) Safety and immunogenicity of intranasally administered inactivated trivalent virosomeformulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. J Infect Dis 181:1129\u20131132","journal-title":"J Infect Dis"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/diacare.22.10.1694","volume":"22","author":"P.M. Graves","year":"1999","unstructured":"Graves PM, Barriga KJ, Norris JM, Hoffman MR, Yu L, Eisenbarth GS, Rewers M (1999) Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 22:1694\u20131697","journal-title":"Diabetes Care"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1128\/JVI.77.9.5218-5225.2003","volume":"77","author":"M. Guebre-Xabier","year":"2003","unstructured":"Guebre-Xabier M, Hammond SA, Epperson DE, Yu J, Ellingsworth L, Glenn GM (2003) Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells. J Virol 77:5218\u20135225","journal-title":"J Virol"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1128\/JVI.78.14.7610-7618.2004","volume":"78","author":"M. Guebre-Xabier","year":"2004","unstructured":"Guebre-Xabier M, Hammond SA, Ellingsworth LR, Glenn GM (2004) Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 78:7610\u20137618","journal-title":"J Virol"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1128\/IAI.70.4.1874-1880.2002","volume":"70","author":"F. G\u00fcere\u00f1a-Burgue\u00f1o","year":"2002","unstructured":"G\u00fcere\u00f1a-Burgue\u00f1o F, Hall ER, Taylor DN, Cassels FJ, Scott DA, Wolf MK, Roberts ZJ, Nesterova GV, Alving CR, Glenn GM (2002) Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun 70:1874\u20131880","journal-title":"Infect Immun"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0169-409X(00)00076-4","volume":"43","author":"S.A. Hammond","year":"2000","unstructured":"Hammond SA, Tsonis C, Sellins K, Rushlow K, Scharton-Kersten T, Colditz I, Glenn GM (2000) Transcutaneous immunization of domestic animals: opportunities and challenges. Adv Drug Deliv Rev 43:45\u201355","journal-title":"Adv Drug Deliv Rev"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i5.30","volume":"18","author":"S.A. Hammond","year":"2001","unstructured":"Hammond SA, Guebre-Xabier M, Yu J, Glenn GM (2001a) Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Crit Rev Ther Drug Carrier Syst 18:503\u2013526","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/S0264-410X(00)00506-5","volume":"19","author":"S.A. Hammond","year":"2001","unstructured":"Hammond SA, Walwender D, Alving CR, Glenn GM (2001b) Transcutaneous immunization: T cell responses and boosting of existing immunity. Vaccine 19:2701\u20132707","journal-title":"Vaccine"},{"key":"14_CR22","first-page":"123","volume-title":"Vaccines","author":"D.A. Henderson","year":"2004","unstructured":"Henderson DA, Borio LL, Lane JM (2004) Smallpox and vaccinia. In Plotkin SA and Orenstein WA (ed) Vaccines. Saunders, Philadelphia, pp 123\u2013153"},{"key":"14_CR23","first-page":"209","volume":"14","author":"T. Jakob","year":"1999","unstructured":"Jakob T, Udey MC (1999) Epidermal Langerhans cells: from neurons to nature\u2019s adjuvants. Adv Dermatol 14:209\u2013258","journal-title":"Adv Dermatol"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1586\/14760584.2.2.167","volume":"2","author":"R.T. Kenney","year":"2003","unstructured":"Kenney RT, Edelman R (2003) Survey of human-use adjuvants. Expert Rev Vaccines 2:167\u2013188","journal-title":"Expert Rev Vaccines"},{"key":"14_CR25","first-page":"213","volume-title":"New Generation Vaccines","author":"R.T. Kenney","year":"2004","unstructured":"Kenney RT, Edelman R (2004a) Adjuvants for the future. In Levine MM (ed) New Generation Vaccines, 3rd Edition. Marcel Dekker, Inc., New York, pp 213\u2013223","edition":"3rd Edition"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa043540","volume":"351","author":"R.T. Kenney","year":"2004","unstructured":"Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM (2004b) Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351:2295\u20132301","journal-title":"N Engl J Med"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1086\/422694","volume":"190","author":"R.T. Kenney","year":"2004","unstructured":"Kenney RT, Yu J, Guebre-Xabier M, Frech SA, Lambert A, Heller BA, Ellingsworth LR, Eyles JE, Williamson ED, Glenn GM (2004c) Induction of protective immunity against lethal anthrax challenge with a patch. J Infect Dis 190:774\u2013782","journal-title":"J Infect Dis"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","volume":"69","author":"K.L. Kotloff","year":"2001","unstructured":"Kotloff KL, Sztein MB, Wasserman SS, Losonsky GA, DiLorenzo SC, Walker RI (2001) Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 69:3581\u20133590","journal-title":"Infect Immun"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1056\/NEJMe048314","volume":"351","author":"J.R. Montagne La","year":"2004","unstructured":"La Montagne JR, Fauci AS (2004) Intradermal influenza vaccination-can less bemore? N Engl J Med 351:2330\u20132332","journal-title":"N Engl J Med"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/IAI.39.2.889-897.1983","volume":"39","author":"M.M. Levine","year":"1983","unstructured":"Levine MM, Ristaino P, Sack RB, Kaper JB, Orskov F, Orskov I (1983) Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun 39:889\u2013897.","journal-title":"Infect Immun"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/eji.1830220915","volume":"22","author":"N. Lycke","year":"1992","unstructured":"Lycke N, Tsuji T, Holmgren J (1992) The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur J Immunol 22:2277\u20132281","journal-title":"Eur J Immunol"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1128\/IAI.66.7.3480-3484.1998","volume":"66","author":"M.P. Matousek","year":"1998","unstructured":"Matousek MP, Nedrud JG, Cieplak W, Jr., Harding CV (1998) Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Infect Immun 66:3480\u20133484","journal-title":"Infect Immun"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1128\/IAI.72.2.1181-1183.2004","volume":"72","author":"G.R. Matyas","year":"2004","unstructured":"Matyas GR, Friedlander AM, Glenn GM, Little S, Yu J, Alving CR (2004) Needle-free skin patch vaccination method for anthrax. Infect Immun 72:1181\u20131183","journal-title":"Infect Immun"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","volume":"116","author":"P. Michetti","year":"1999","unstructured":"Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, Herranz M, Saldinger PF, Corthesy-Theulaz I, Losonsky G, Nichols R, Simon J, Stolte M, Ackerman S, Monath TP, Blum AL (1999) Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116:804\u2013812","journal-title":"Gastroenterology"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm0402-415","volume":"8","author":"J.A. Mikszta","year":"2002","unstructured":"Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8:415\u2013419","journal-title":"Nat Med"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","volume":"350","author":"M. Mutsch","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R (2004) Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland. N Engl J Med 350:896\u2013903","journal-title":"N Engl J Med"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1385\/1-59259-083-7:327","volume-title":"Vaccine Adjuvants: Preparation Methods and Research Protocols","author":"J.A. Neidleman","year":"2000","unstructured":"Neidleman JA, Ott G, O\u2019Hagan D (2000) Mutant heat-labile enterotoxins as adjuvants for CTL induction. In O\u2019Hagan D (ed) Vaccine Adjuvants: Preparation Methods and Research Protocols. Humana Press, Totowa, NJ, pp 327\u2013336"},{"key":"14_CR38","volume-title":"Methods in Molecular Medicine","year":"2000","unstructured":"O\u2019Hagan DT, ed. (2000) Methods in Molecular Medicine, Humana Press, Inc., Totowa, NJ"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1542\/peds.111.3.653","volume":"111","author":"P.A. Offit","year":"2003","unstructured":"Offit PA, Hackett CJ (2003) Addressing parents\u2019 concerns: do vaccines cause allergic or autoimmune diseases? Pediatrics 111:653\u2013659","journal-title":"Pediatrics"},{"key":"14_CR40","first-page":"141","volume":"2","author":"W.F. Page","year":"1993","unstructured":"Page WF, Norman JE, Benenson AS (1993) Long-term follow-up of army recruits immunized with Freund\u2019s incomplete adjuvanted vaccine. Vaccine Research 2:141\u2013149","journal-title":"Vaccine Research"},{"key":"14_CR41","first-page":"335","volume":"19","author":"R. Panchagnula","year":"1997","unstructured":"Panchagnula R, Stemmer K, Ritschel WA (1997) Animal models for transdermal drug delivery. Methods Find Exp Clin Pharmacol 19:335\u2013341","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1586\/14760584.2.2.285","volume":"2","author":"S. Peppoloni","year":"2003","unstructured":"Peppoloni S, Ruggiero P, Contorni M, Morandi M, Pizza M, Rappuoli R, Podda A, Del Giudice G (2003) Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Expert Rev Vaccines 2:285\u2013293","journal-title":"Expert Rev Vaccines"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.158.2.834","volume":"158","author":"A. Porgador","year":"1997","unstructured":"Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ (1997) Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J Immunol 158:834\u2013841","journal-title":"J Immunol"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1001\/jama.254.22.3203","volume":"254","author":"R.R. Redfield","year":"1985","unstructured":"Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH (1985) Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine.A cost reduction strategy. JAMA 254:3203\u20133206","journal-title":"JAMA"},{"key":"14_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000080218","volume":"17","author":"T. Richter","year":"2004","unstructured":"Richter T, Peuckert C, Sattler M, Koenig K, Riemann I, Hintze U, Wittern KP, Wiesendanger R, Wepf R (2004) Dead but highly dynamic-the stratum corneum is divided into three hydration zones. Skin Pharmacol Physiol 17:246\u2013257","journal-title":"Skin Pharmacol Physiol"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4049\/jimmunol.172.1.302","volume":"172","author":"D.S. Riminton","year":"2004","unstructured":"Riminton DS, Kandasamy R, Dravec D, Basten A, Baxter AG (2004) Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease. J Immunol 172:302\u2013309","journal-title":"J Immunol"},{"key":"14_CR47","volume-title":"Water, the most natural penetration enhancer","author":"M.S. Roberts","year":"1993","unstructured":"Roberts MS, Walker M (1993) Water, the most natural penetration enhancer, Marcel Dekker, New York"},{"key":"14_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","volume":"19","author":"M.J. Roy","year":"2000","unstructured":"Roy MJ, Wu MS, Barr LJ, Fuller JT, Tussey LG, Speller S, Culp J, Burkholder JK, Swain WF, Dixon RM, Widera G, Vessey R, King A, Ogg G, Gallimore A, Haynes JR, Heydenburg Fuller D (2000) Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19:764\u2013778","journal-title":"Vaccine"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1080\/00015550310015419","volume":"83","author":"J. Sandby-Moller","year":"2003","unstructured":"Sandby-Moller J, Poulsen T, Wulf HC (2003) Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol 83:410\u2013413","journal-title":"Acta Derm Venereol"},{"key":"14_CR50","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1128\/IAI.68.9.5306-5313.2000","volume":"68","author":"T. Scharton-Kersten","year":"2000","unstructured":"Scharton-Kersten T, Yu J, Vassell R, O\u2019Hagan D, Alving CR, Glenn GM (2000) Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect Immun 68:5306\u20135313","journal-title":"Infect Immun"},{"key":"14_CR51","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1073\/pnas.97.1.371","volume":"97","author":"N. Seo","year":"2000","unstructured":"Seo N, Tokura Y, Nishijima T, Hashizume H, Furukawa F, Takigawa M (2000) Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci USA 97:371\u2013376","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1046\/j.1365-3083.2001.00884.x","volume":"53","author":"C.P. Simmons","year":"2001","unstructured":"Simmons CP, Ghaem-Magami M, Petrovska L, Lopes L, Chain BM, Williams NA, Dougan G (2001) Immunomodulation using bacterial enterotoxins. Scand J Immunol 53:218\u2013226","journal-title":"Scand J Immunol"},{"key":"14_CR53","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v15.i3-4.70","volume":"15","author":"D.P. Snider","year":"1995","unstructured":"Snider DP (1995) The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit Rev Immunol 15:317\u2013348","journal-title":"Crit Rev Immunol"},{"issue":"Suppl 1","key":"14_CR54","first-page":"6","volume":"107","author":"M.C. Udey","year":"1997","unstructured":"Udey MC (1997) Cadherins and Langerhans cell immunobiology. Clin Exp Immunol 107Suppl 1:6\u20138","journal-title":"Clin Exp Immunol"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1128\/IAI.68.5.2775-2782.2000","volume":"68","author":"R. Weltzin","year":"2000","unstructured":"Weltzin R, Guy B, Thomas WD, Jr., Giannasca PJ, Monath TP (2000) Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun 68:2775\u20132782","journal-title":"Infect Immun"},{"key":"14_CR56","unstructured":"Wolf M, Hall E, Taylor D, Coster T, Trespalacios F, Cassels F, deLorimier A, McQueen C (1999) Use of the human challenge model to characterize the immune response to the colonization factors of enterotoxigenic Escherichia coli (ETEC). The 35th U.S.-Japan Cholera and Other Bacterial Enteric Infections Joint Panel Meeting. Baltimore, MD."},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1574-6968.1997.tb10263.x","volume":"148","author":"M.K. Wolf","year":"1997","unstructured":"Wolf MK, de Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, and Gaastra W (1997) The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits. FEMS Microbiol Lett 148:35\u201342","journal-title":"FEMS Microbiol Lett"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1128\/IAI.70.3.1056-1068.2002","volume":"70","author":"J. Yu","year":"2002","unstructured":"Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, Angov E, Corthesy B, Alving C, Glenn G (2002) Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun 70:1056\u20131068","journal-title":"Infect Immun"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1365-2133.1994.tb08587.x","volume":"131","author":"R.C. Yu","year":"1994","unstructured":"Yu RC, Abrams DC, Alaibac M, Chu AC (1994) Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy. Br J Dermatol 131:843\u2013848","journal-title":"Br J Dermatol"},{"key":"14_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1586\/14760584.2.2.295","volume":"2","author":"R. Zurbriggen","year":"2003","unstructured":"Zurbriggen R, Metcalfe IC, Gluck R, Viret JF, Moser C (2003) Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine. Expert Rev Vaccines 2:295\u2013304","journal-title":"Expert Rev Vaccines"}],"container-title":["Current Topics in Microbiology and Immunology","Mass Vaccination: Global Aspects \u2014 Progress and Obstacles"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-36583-4_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T22:36:25Z","timestamp":1683585385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-36583-4_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783540293828"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/3-540-36583-4_14","relation":{},"subject":[]}}